Medtronic Plc (MDT US)

258

Analysis

Health Care • United States

Medtronic, PLC develops therapeutic and diagnostic medical products. The Company's principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic's products are sold worldwide.

Refresh

Company Event • 16 Sep 2026 04:05 • Latest

Morgan Stanley 24th Annual Global Healthcare Conference

Company Event • 08 Sep 2026 23:35

Wells Fargo 21st Annual Healthcare Conference

Company Event • 17 Aug 2026 20:00 • Upcoming

Add To Calendar

Proxy filing

Company Event • 17 Aug 2026 20:00 • Upcoming

Add To Calendar

Proxy filing

Company Event • 11 Mar 2026 21:20

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Morgan Stanley 24th Annual Global Healthcare Conference

Wells Fargo 21st Annual Healthcare Conference

Proxy filing

Proxy filing

Leerink Global Healthcare Conference 2026